Filing Manager
CITADEL ADVISORS LLC
Reporting Manager
Kenneth Griffin
Shares outstanding
34,632,638 shares
Disclosed Ownership
1,627,734 shares
Ownership
4.7%
Form type
SCHEDULE 13G/A
Filing time
14 Feb 2025, 18:24:06 UTC
Date of event
31 Dec 2024

Quoteable Key Fact

"CITADEL ADVISORS LLC disclosed 4.7% ownership in Protara Therapeutics, Inc. Common Stock, $0.001 par value per share (the "Shares") on 31 Dec 2024."

Quick Takeaways

  • CITADEL ADVISORS LLC filed SCHEDULE 13G/A for Protara Therapeutics, Inc. Common Stock, $0.001 par value per share (the "Shares").
  • Disclosed ownership: 4.7%.
  • Date of event: 31 Dec 2024.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 14 Feb 2025, 18:24.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Source Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (7)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Citadel Advisors LLC 4.6% 1,612,531 0 1,612,531 /s/ Seth Levy Seth Levy, Authorized Signatory
Citadel Advisors Holdings LP 4.6% 1,612,531 0 1,612,531 /s/ Seth Levy Seth Levy, Authorized Signatory
Citadel GP LLC 4.6% 1,612,531 0 1,612,531 /s/ Seth Levy Seth Levy, Authorized Signatory
Citadel Securities LLC 0% 15,203 0 15,203 /s/ Guy Miller Guy Miller, Authorized Signatory
Citadel Securities Group LP 0% 15,203 0 15,203 /s/ Guy Miller Guy Miller, Authorized Signatory
Citadel Securities GP LLC 0% 15,203 0 15,203 /s/ Guy Miller Guy Miller, Authorized Signatory
Kenneth Griffin 4.7% 1,627,734 0 1,627,734 /s/ Seth Levy Seth Levy, attorney-in-fact*
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .